Heart attack patients may soon skip aspirin after stenting
NCT ID NCT05785897
First seen Jan 08, 2026 · Last updated Apr 29, 2026 · Updated 12 times
Summary
This study looks at 350 people who had a severe heart attack (STEMI) and received a stent. It compares the usual treatment—taking aspirin plus a second blood thinner for 6–12 months—against a newer approach: using a special stent that releases medication without a polymer, plus taking only one blood thinner (no aspirin). The goal is to see if the new plan lowers the risk of serious bleeding while still preventing future heart problems, strokes, or the need for another procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ST ELEVATION MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Geneva University Hospitals
RECRUITINGGeneva, Canton of Geneva, 1205, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zurich University Hospital
RECRUITINGZurich, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.